Who Gets Access? Understanding the New Reality of Cancer Drug Coverage

Are oncology treatments losing their "special status" with payers? In this episode of Value-Based Voices, host Brian Reid, MS, Principal of Reid Strategic and author of the Cost Curve newsletter, sits down with James Chambers, PhD, MSc, MPharm, Professor at Tufts University School of Medicine and Director of the Specialty Drug Evidence and Coverage (SPEC) Database, to examine how payer coverage decisions are shaping access to cancer therapies in the United States. Drawing on nearly a ...